Lipopolysaccharide-binding protein: A possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients

Intensive Care Medicine

Volumn 29, Issue 12, 2003, Pages 2157-2161

  Oude Nijhuis, Claudi S M ^a   Vellenga, Edo ^b   Daenen, Simon M G J ^b   Van Der Graaf, Winette T A ^b   Gietema, Jourik A ^b   Groen, Harry J M ^b   Kamps, Willem A ^a   De Bont, Eveline S J M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer; Fever; Infection bacteremia; Lipopolysaccharide binding protein; Neutropenia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CANCER PATIENT; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN DETERMINATION; PYREXIA IDIOPATHICA;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER OF UNKNOWN ORIGIN; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 0348225263     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-003-2026-2     Document Type: Article

References (17)

1. Bodey GP, Buckley M, Sathe YS (1966) Quantitative relationship between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 64:328-340
2. Talcott JA, Finberg R, Mayer RJ, Goldman L (1988) The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Arch Intern Med 148:2561-2568
3. Sickles EA, Greene WH, Wiernik PH (1975) Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 135:715-719
4. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll B, Freudenberg M, Schmitz G, Stelter F, Schutt C (1997) Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389:742-745
5. Faure E, Equils O, Sieling PA (2000) Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem 275:11058-11063
6. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ (1998) Toll-like receptor-2 mediates lipopolysaccharide- induced cellular signalling. Nature 395:284-288
7. Vreugdenhil AC, Snoek AM, Van 't Veer C (2001) LPS-binding protein circulated in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. J Clin Invest 107:234
8. Martin TR, Rubenfeld GD, Ruzinski JT, Goodman RB, Steinberg KP, Leturcq DJ, Moriarty AM, Raghu G, Baughman RP, Hudson LD (1997) Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:937-944
9. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584-1589
10. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
11. Engel A, Mack E, Kern P, Kern WV (1998) An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 26:213-221
12. Bont ESJM de, Vellenga E, Swaanenburg JCJM, Kamps WA (2000) Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 28:398-400
13. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115:53-57
14. Bont ESJM de, Vellenga E, Swaanenburg JC, Fidler V, Visser-van Brummen PJ, Kamps WA (1999) Plasma JL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol 107:375-380
15. Waage A, Remick D, Steinshamn S, DeForge L, Lamvik J (1994) Interleukin 8 in serum in granulocytopenic patients with infections. Br J Haematol 86:36-40
16. Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA (1998) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341:305-311
17. Pizzo PA (1993) Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 328:1323-1332